Immer mehr Unternehmen setzen sich öffentlich für die Umsetzung der Agenda 2030 ein und beziehen sich in ihren Nachhaltigkeitsberichten auf die Ziele für nachhaltige Entwicklung (SDGs). Ihre Unternehmenspraxis sieht jedoch oft anders aus: Immer wieder klagen Betroffe...ne über Menschenrechtsverletzungen und Umweltverschmutzung entlang der Lieferkette transnationaler Unternehmen. Der Umsetzungsprozess der Agenda 2030 wird von einer wachsenden Zahl von Wirtschaftsakteuren als willkommene Gelegenheit gesehen, dieser Kritik zu begegnen, den Diskurs in ihrem Sinne zu gestalten und politische Entscheidungen entsprechend zu beeinflussen.Das Briefing zeigt auf, dass das Engagement der Wirtschaft für die SDGs und der Unternehmenseinfluss auf den SDG-Diskurs mit Risiken und Nebenwirkungen verbunden sind. Sie betreffen die Botschaften, die Problemanalysen, die Lösungsvorschläge und die von führenden Wirtschaftsvertreter/innen befürworteten Governance-Modelle.
more
This manual is a resource for Health Counselors working in Family Physician Clinics (FPC) as part of the MANAS program. This program is for common mental disorders like depression and anxiety seen in primary health care facilitieslike the FPC; since depression is the common...est disorder within this group of stress related mental health problems, in the manual we refer to these problems simply as ‘Depression’. The aim of the MANAS program is to integrate the recognition and treatment of Depression into routine primary health care.In the MANAS program, a range of effective treatments will be provided for patients with Depression. These treatments are matched to the individual requirements of patients to both improve the effectiveness of the treatments and to use the limited resources efficiently.
more
The Committee examined the clinical development of Ebola virus vaccines and conducted an inventory of available data on their safety. It also reviewed 3 generic issues: updating a global strategy on vaccine safety, use of a network of distributed data ... to monitor the safety of vaccines and case studies of communication about the safety of human papillomavirus (HPV) vaccines.
Weekly epidemiological record/Relevé épidémiologique hebdomadaire 12 JULY 2019, 94th YEAR / 12 JUILLET 2019, 94e ANNÉENo 28, 2019, 94, 309–316
more
Laboratory Biossafety Manual
Für viele Städte ist eine klimafreundliche Mobilität eine Herausforderung, der sie sich zunehmend stellen. Viele Fragen stehen im Raum: wie sieht Mobilität und eine Stadt von morgen aus? Wie komme ich klima- und umweltfreundlich zur Schule und zur Arbeit? Was für eine Wende ist dafür nötig un...d wie könnte diese aussehen? Das Unterrichtsmaterial „Verkehr(t)!“ regt die Schüler*innen dazu an, das Verkehrsverhalten in ihrer Umwelt zu analysieren und ihre eigene Mobilität kritisch unter die Lupe zu nehmen. Sie erkunden, welche Bedeutung Verkehr für Umwelt und Klima hat und identifizieren Stellen, an denen Handeln möglich und notwendig ist.
more
Die 169 Unterziele im Einzelnen
Le présent Plan National de Développement Sanitaire (PNDS) couvre la période 2009-2018. Il s’inscrit dans la perspective de l’accélération de la mise en œuvre des différents programmes de prévention et d’offres de services de santé. Son objectif est de contribuer à l’atteinte des o...bjectifs du Document de Stratégie de Réduction de la Pauvreté et des Objectifs du Millénaire pour le Développement.
Le PNDS 2009-2018 est le document de référence pour l’ensemble des acteurs du secteur de la santé. Je les engage donc, ainsi que tous les partenaires à se l’approprier et à contribuer à sa mise en œuvre performante.
more
This document provides guidance on the application of non-pharmaceutical countermeasures to minimise the spread of the 2019 novel coronavirus (2019-nCoV) in the population. Some of the measures proposed refer specifically to certain phases of the epidemic (containment or mitigation phases), and can ...be adapted depending on the assessed severity/impact of the infection. Other measures are valid for all phases of an epidemic.
The guidance is based on the current knowledge of the 2019-nCoV and evidence available on other viral respiratory pathogens, mainly the Severe Acute Respiratory Syndrome coronavirus (SARS-CoV), the Middle East Respiratory Syndrome-related coronavirus (MERS-CoV) and seasonal or pandemic influenza viruses.
more
Research Article
Karo et al. BMC Infectious Diseases 2014, 14:148 http://www.biomedcentral.com/1471-2334/14/148
Kenya reported its first case of COVID-19 on 12 March 2020 and, as at 7 April 2020, 172 cases had been confirmed and 6 deaths reported. The Government of Kenya has taken a number of measures to curb the spread of the virus, including implementing a curfew, restricting movement out and into four coun...ties, including Nairobi Metropolitan, and closing most of the urban and rural markets to enforce social distancing. However, these measures, along with the global economic shock caused by the pandemic, are expected to generate new needs, requiring an immediate and urgent response.
more
March 2020
The number of African Union Member States reporting COVID-
19 cases is increasing and there is a likelihood of community transmission. The WHO recently modified the COVID-19 suspect case definition to include severe acute respiratory infection and advises testing of all severe acute res...piratory illness (SARI) cases.1 However, many Member States have not yet started implementing these changes, they are still focussing surveillance efforts on individuals with travel history to an area with local COVID-19 transmission. This means patients with similar symptoms, but no apparent contact, may not
be investigated.
more
This technical brief was developed by the UNFPA Global Ageing Network to complement the UN Department of Economic and Social Affairs' (UN DESA) Issue Brief: Older Persons and COVID-19, which emphasized the humanitarian imperative of addressing older persons' specific needs within preparedness and re...sponse to the COVID-19 pandemic.
more
This Interim Guidance outlines how key public health and social measures needed to reduce the risk of COVID-19 spread and the impact of the disease can be adapted for use in low capacity and humanitarian settings. The recommendations outlined here need to be adjusted to the scale of transmission, co...ntext and resources, in order to achieve the objective of managing COVID-19, namely to reduce transmission and facilitate the detection and management of infected and exposed individuals within the population. The Guidance is intended for humanitarian and development actors of all operational levels working with communities ocal authorities involved in COVID-19 preparedness and response operations in these settings, in support of national and local governments and plans. Additional considerations for support to residents of urban informal settlements and slums are available in Annex 1.
more
Everyday experience shows that there is a commonality between spirituality and medical practice. A text message I received from a friend recently read, "Please pray for me. I've been getting a mysterious headache for some days now. I will be seeing the doctor today." This clearly speaks of a relatio...nship: asking for prayer so as to be relieved of a "mysterious headache", yet going to see a doctor whose job is not to cure mysterious headaches. Even though both areas of human experience have their peculiar and largely unrelated methodologies, this paper argues that any extreme separation of the two is injurious to the teleology of both disciplines in relation to human well-being, which forms the core of spirituality and medicine.
more
Interim guidance, 6 October 2021
Direct detection of SARS-CoV-2 viral proteins (antigens) in nasal swabs and other respiratory secretions using lateral flow immunoassays (also known as rapid diagnostic tests, RDTs) offers a faster and less expensive method to test for SARS-CoV-2 than the reference ...method, nucleic acid amplification tests (NAATs). This interim guidance offers recommendations on the priority uses of antigen-detecting rapid diagnostic tests (Ag-RDTs) in specific populations and settings, including (i) for primary case detection in symptomatic individuals suspected to be infected and asymptomatic individuals at high risk of COVID-19, (ii) for contact tracing, (iii) during outbreak investigations and (iv) to monitor trends of disease incidence in communities. Ag-RDTs meeting minimum performance requirements can be used outside of clinical and laboratory settings, including in communities, by trained operators in accordance with instructions. The guidance additionally provides recommendations on implementation, product selection and storage.
more
Conflict, climate crisis and COVID-19 pose great threats to the health of women and children.